Unknown

Dataset Information

0

PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice.


ABSTRACT: Deposition of plaques containing amyloid beta (Abeta) peptides is a neuropathological hallmark of Alzheimer's disease (AD). Here we demonstrate that neuronal overexpression of the epsilon isozyme of PKC decreases Abeta levels, plaque burden, and plaque-associated neuritic dystrophy and reactive astrocytosis in transgenic mice expressing familial AD-mutant forms of the human amyloid precursor protein (APP). Compared with APP singly transgenic mice, APP/PKCepsilon doubly transgenic mice had decreased Abeta levels but showed no evidence for altered cleavage of APP. Instead, PKCepsilon overexpression selectively increased the activity of endothelin-converting enzyme, which degrades Abeta. The activities of other Abeta-degrading enzymes, insulin degrading enzyme and neprilysin, were unchanged. These results indicate that increased neuronal PKCepsilon activity can promote Abeta clearance and reduce AD neuropathology through increased endothelin-converting enzyme activity.

SUBMITTER: Choi DS 

PROVIDER: S-EPMC1472455 | BioStudies | 2006-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2006-01-01 | S-EPMC2846286 | BioStudies
1000-01-01 | S-EPMC3823109 | BioStudies
2008-01-01 | S-EPMC2100431 | BioStudies
1000-01-01 | S-EPMC4068634 | BioStudies
2009-01-01 | S-EPMC2677455 | BioStudies
2013-05-14 | E-GEOD-46871 | ArrayExpress
2005-01-01 | S-EPMC2593886 | BioStudies
2009-01-01 | S-EPMC2709991 | BioStudies
2010-01-01 | S-EPMC2910136 | BioStudies
| S-EPMC3323924 | BioStudies